The FDA has expanded the approval of Odactra to include treatment of house dust mite-induced allergic rhinitis in pediatric patients aged 5 to 11 years.

Research indicates that between 17 and 40 million Americans suffer from vasomotor rhinitis and that Americans spend a minimum of $1.8 billion in treatment costs each year. A runny nose with ...

Xyzal (levocetirizine) and Zyrtec (cetirizine) are over-the-counter (OTC) allergy medications. Learn about their key ...

Eosinophils play a crucial role in allergic responses, secreting cytokines and inflammatory mediators that exacerbate AR ...

Patients' asthma status should be carefully evaluated before the initiation of treatment'. 12 SQ-HDM SLIT is also indicated ... with persistent moderate to severe house dust mite allergic rhinitis ...

Rhinitis and pharmacological agents used for treatment are considered factors that could alter the rate and extent of absorption of drugs administered by the nasal route. The purpose of this study ...

The U.S. Food and Drug Administration has expanded its indication of ALK's Odactra, a house dust mite allergen tablet, for ...

For most children, symptoms may be controlled by avoiding the allergen, if known, and using nonprescription medicines. But if a child's symptoms are persistent and not relieved by nonprescription ...

The World Health Organization (WHO) points out that causes range from infections to environmental factors, and without treatment, the discomfort can worsen over time. Atrophic rhinitis is more ...